المؤلفون: Patin, EC, Willcocks, S, Orr, S, Ward, TH, Lang, R, Schaible, UE

المصدر: Patin, EC, Willcocks, S, Orr, S, Ward, TH, Lang, R & Schaible, UE 2016, ' Mincle-mediated anti-inflammatory IL-10 response counter-regulates IL-12 in vitro. ', Innate Immunity . https://doi.org/10.1177/1753425916636671

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______2607::8e79048844da4cc3032e5d7b72fe3ce5
https://pure.qub.ac.uk/en/publications/minclemediated-antiinflammatory-il10-response-counterregulates-il12-invitro(aeaa3a4d-a049-4f5f-b957-e624d3da4b22).html

المؤلفون: Melake, MJ, Smith, HG, Mansfield, D, Davies, E, Dillon, MT, Wilkins, AC, Patin, EC, Pedersen, M, Buus, R, Melcher, AA, Thway, K, Miah, AB, Zaidi, SH, Hayes, AJ, Fenton, TR, Harrington, KJ, McLaughlin, M

المصدر: OncoImmunology; December 2022, Vol. 11 Issue: 1

المؤلفون: Mannion J; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Gifford V; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Bellenie B; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Fernando W; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Ramos Garcia L; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Wilson R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., John SW; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Udainiya S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Patin EC; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Tiu C; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Smith A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Goicoechea M; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Craxton A; MRC Toxicology Unit, University of Cambridge, Gleeson Building, Cambridge CB2 1QR, UK., Moraes de Vasconcelos N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Guppy N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Cheung KJ; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Cundy NJ; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Pierrat O; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Brennan A; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Roumeliotis TI; Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, UK., Benstead-Hume G; Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, UK., Alexander J; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Muirhead G; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Layzell S; Institute of Immunity and Transplantation, University College London, London NW3 2PP, UK., Lyu W; Department of Immunology and Microbiology, LEO Foundation Skin Immunology Research Center, University of Copenhagen, Copenhagen, Denmark., Roulstone V; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Allen M; Biological Services Unit, The Institute of Cancer Research, London SW3 6JB, UK., Baldock H; Biological Services Unit, The Institute of Cancer Research, London SW3 6JB, UK., Legrand A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Gabel F; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Serrano-Aparicio N; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Starling C; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Guo H; Department of Microbiology and Immunology, LSU Health Shreveport, Shreveport, LA, USA., Upton J; Department of Biological Sciences, Auburn University, Auburn, AL, USA., Gyrd-Hansen M; Department of Immunology and Microbiology, LEO Foundation Skin Immunology Research Center, University of Copenhagen, Copenhagen, Denmark., MacFarlane M; MRC Toxicology Unit, University of Cambridge, Gleeson Building, Cambridge CB2 1QR, UK., Seddon B; Institute of Immunity and Transplantation, University College London, London NW3 2PP, UK., Raynaud F; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Roxanis I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Harrington K; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Choudhary JS; Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, UK., Hoelder S; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Tenev T; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK. Electronic address: tencho.tenev@icr.ac.uk., Meier P; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK. Electronic address: pmeier@icr.ac.uk.

المصدر: Immunity [Immunity] 2024 Jul 09; Vol. 57 (7), pp. 1514-1532.e15. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE

مواضيع طبية MeSH: Receptor-Interacting Protein Serine-Threonine Kinases*/metabolism , Proteolysis*/drug effects , Signal Transduction*/drug effects , Immunogenic Cell Death*/drug effects, Humans ; Animals ; Mice ; Cell Line, Tumor ; Necroptosis/drug effects ; Necroptosis/immunology ; Neoplasms/immunology ; Neoplasms/drug therapy ; Mice, Inbred C57BL ; Antineoplastic Agents/pharmacology ; Immunotherapy/methods

المؤلفون: Dillon MT; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Guevara J; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Mohammed K; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Patin EC; The Institute of Cancer Research, London, United Kingdom., Smith SA; Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Dean E; Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Jones GN; Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Willis SE; Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Petrone M; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Silva C; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Thway K; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Bunce C; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Roxanis I; The Institute of Cancer Research, London, United Kingdom., Nenclares P; The Institute of Cancer Research, London, United Kingdom., Wilkins A; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., McLaughlin M; The Institute of Cancer Research, London, United Kingdom., Jayme-Laiche A; UCL Cancer Institute and University College London Hospital NHS Foundation Trust, London, United Kingdom., Benafif S; UCL Cancer Institute and University College London Hospital NHS Foundation Trust, London, United Kingdom., Nintos G; King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Kwatra V; King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Grove L; The Institute of Cancer Research, London, United Kingdom., Mansfield D; The Institute of Cancer Research, London, United Kingdom., Proszek P; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Martin P; Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Moore L; Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Swales KE; The Institute of Cancer Research, London, United Kingdom., Banerji U; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Saunders MP; The Christie NHS Foundation Trust, Manchester, United Kingdom., Spicer J; King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Forster MD; UCL Cancer Institute and University College London Hospital NHS Foundation Trust, London, United Kingdom., Harrington KJ; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom.

المصدر: The Journal of clinical investigation [J Clin Invest] 2024 Jan 16; Vol. 134 (2). Date of Electronic Publication: 2024 Jan 16.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/genetics , Neoplasms*/pathology , Morpholines* , Pyrimidines* , Sulfonamides*, Humans ; Indoles ; Inflammation/drug therapy ; Genomics ; Ataxia Telangiectasia Mutated Proteins/genetics

المؤلفون: Chan Wah Hak CML; Translational Immunotherapy Team, The Institute of Cancer Research, London, United Kingdom., Rullan A; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom., Patin EC; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom., Pedersen M; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom., Melcher AA; Translational Immunotherapy Team, The Institute of Cancer Research, London, United Kingdom., Harrington KJ; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.

المصدر: Frontiers in oncology [Front Oncol] 2022 Aug 29; Vol. 12, pp. 971959. Date of Electronic Publication: 2022 Aug 29 (Print Publication: 2022).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Patin EC; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK emmanuel.patin@icr.ac.uk., Dillon MT; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Nenclares P; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK., Grove L; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK., Soliman H; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK., Leslie I; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK., Northcote D; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK., Bozhanova G; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Crespo-Rodriguez E; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Baldock H; Biological Services Unit, The Institute of Cancer Research, London, UK., Whittock H; Biological Services Unit, The Institute of Cancer Research, London, UK., Baker G; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Kyula J; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Guevara J; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK., Melcher AA; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Harper J; Early Oncology R&D, AstraZeneca, Cambridge, UK., Ghadially H; Early Oncology R&D, AstraZeneca, Cambridge, UK., Smith S; Early Oncology R&D, AstraZeneca, Cambridge, UK., Pedersen M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., McLaughlin M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Harrington KJ; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Mar; Vol. 10 (3).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Ataxia Telangiectasia* , Carcinoma, Squamous Cell*/drug therapy , Carcinoma, Squamous Cell*/radiotherapy , Head and Neck Neoplasms* , Mouth Neoplasms* , Papillomavirus Infections*, Animals ; DNA Damage ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Mice ; Programmed Cell Death 1 Receptor ; Receptors, Immunologic ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/radiotherapy ; Tumor Microenvironment

المؤلفون: Bozhanova G; Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK., Hassan J; Imperial College London, London, UK., Appleton L; Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK.; Imperial College London, London, UK., Jennings V; Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK., Foo S; Radiotherapy & Imaging, The Institute of Cancer Research, London, UK., McLaughlin M; Institute of Cancer Research, London, UK., Chan Wah Hak CM; Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK., Patin EC; Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK., Crespo-Rodriguez E; Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK., Baker G; Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK., Armstrong E; Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK., Chiu M; Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK., Pandha H; Oncology, University of Surrey, Guildford, UK., Samson A; Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK., Roulstone V; Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK., Kyula J; Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK., Vile R; Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Errington-Mais F; Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK., Pedersen M; Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK., Harrington K; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Ono M; Imperial College London, London, UK., Melcher A; Institute of Cancer Research, London, UK alan.melcher@icr.ac.uk.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Mar; Vol. 10 (3).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Herpes Simplex* , Melanoma*/drug therapy , Oncolytic Viruses*/physiology, Animals ; CD4-Positive T-Lymphocytes ; Humans ; Immunity ; Mice ; Mice, Inbred C57BL ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins B-raf/genetics

المؤلفون: Crespo-Rodriguez E; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom., Bergerhoff K; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom., Bozhanova G; Translational Immunotherapy Team, The Institute of Cancer Research, London, United Kingdom., Foo S; Translational Immunotherapy Team, The Institute of Cancer Research, London, United Kingdom., Patin EC; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom., Whittock H; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom., Buus R; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, United Kingdom., Haider S; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Muirhead G; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Thway K; Sarcoma Unit, The Royal Marsden Hospital, London, United Kingdom., Newbold K; Head and Neck/Thyroid Oncology Department, The Royal Marsden Hospital, London, United Kingdom., Coffin RS; Replimune Inc, Woburn, Massachusetts, United States., Vile RG; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, United States., Kim D; Head and Neck Department, St George's University Hospital, London, United Kingdom., McLaughlin M; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom., Melcher AA; Translational Immunotherapy Team, The Institute of Cancer Research, London, United Kingdom., Harrington KJ; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom., Pedersen M; Translational Immunotherapy Team, The Institute of Cancer Research, London, United Kingdom malin.pedersen@icr.ac.uk.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Aug; Vol. 8 (2).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Oncolytic Virotherapy/*methods , Proto-Oncogene Proteins B-raf/*metabolism , Thyroid Neoplasms/*genetics, Animals ; Cell Line, Tumor ; Disease Models, Animal ; Female ; Herpesvirus 1, Human/pathogenicity ; Humans ; Male ; Mice ; Thyroid Neoplasms/pathology

المؤلفون: Chiu M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Armstrong EJL; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Jennings V; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Foo S; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Crespo-Rodriguez E; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Bozhanova G; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Patin EC; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., McLaughlin M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Mansfield D; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Baker G; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Grove L; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Pedersen M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Kyula J; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Roulstone V; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Wilkins A; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., McDonald F; The Royal Marsden NHS Foundation Trust, London, UK., Harrington K; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Melcher A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK.

المصدر: Expert opinion on biological therapy [Expert Opin Biol Ther] 2020 Jun; Vol. 20 (6), pp. 635-652. Date of Electronic Publication: 2020 Feb 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Immune Checkpoint Inhibitors/*therapeutic use , Neoplasms/*therapy , Oncolytic Virotherapy/*methods, Adenoviridae/physiology ; Antibodies, Monoclonal, Humanized/therapeutic use ; Combined Modality Therapy ; Enterovirus/physiology ; Humans ; Neoplasms/drug therapy ; Neoplasms/pathology ; Orthoreovirus/physiology ; Vaccinia virus/physiology

المؤلفون: McLaughlin M; Targeted Therapy Team, The Institute of Cancer Research, London, UK. martin.mclaughlin@icr.ac.uk., Patin EC; Targeted Therapy Team, The Institute of Cancer Research, London, UK., Pedersen M; Translational Immunotherapy Team, The Institute of Cancer Research, London, UK., Wilkins A; The Royal Marsden Hospital, London, UK., Dillon MT; Targeted Therapy Team, The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital, London, UK., Melcher AA; Translational Immunotherapy Team, The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital, London, UK., Harrington KJ; Targeted Therapy Team, The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital, London, UK.

المصدر: Nature reviews. Cancer [Nat Rev Cancer] 2020 Apr; Vol. 20 (4), pp. 203-217. Date of Electronic Publication: 2020 Mar 11.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124168 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1768 (Electronic) Linking ISSN: 1474175X NLM ISO Abbreviation: Nat Rev Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment*/immunology , Tumor Microenvironment*/radiation effects, Neoplasms/*etiology , Neoplasms/*pathology, Animals ; Antigen Presentation/immunology ; Antigen Presentation/radiation effects ; Biomarkers, Tumor ; Caspases/metabolism ; DNA Repair ; Disease Susceptibility ; Exosomes/metabolism ; Humans ; Membrane Proteins/metabolism ; Molecular Targeted Therapy ; Neoplasms/radiotherapy ; Nucleotidyltransferases/metabolism ; Protein Processing, Post-Translational ; Radiotherapy/adverse effects ; Radiotherapy/methods ; Signal Transduction